EUVIMEDEUVIMED entdecken
Crossref

[ 99m Tc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction

Alessandro Liebich iD, Ralph A Bundschuh, Christian H Pfob iD, Malte Kircher, Georgine Wienand iD, Philip Raake, Stephan G Nekolla iD, Margret Schottelius iD, Takahiro Higuchi iD, Maximilian Rieger iD, Constantin Lapa

Circulation: Cardiovascular Imaging · 2024

DOI: 10.1161/circimaging.124.016992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2024. Verfasst von Alessandro Liebich und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, Faculty of Medicine (A.L., R.A.B., C.H.P., M.K., G.W., C.L.), University of Augsburg, Germany. Hauptthemen laut MEDLINE: Myocardial Infarction, Receptors, CXCR4, Radiopharmaceuticals, Single Photon Emission Computed Tomography Computed Tomography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Accumulation of CXCR4 (C-X-C motif chemokine receptor 4)–positive immune cells after acute myocardial infarction (AMI) can be visualized by positron emission tomography. For a broader clinical application, there is a need for CXCR4-directed radiotracers labeled with isotopes that can be used with single-photon emission computed tomography (SPECT). We report on the detection of CXCR4 expression after AMI in humans using the novel tracer [ 99m Tc]-PentixaTec. METHODS: In this retrospective analysis, 9 patients with AMI after mechanical revascularization underwent myocardial inflammation imaging with [ 99m Tc]-PentixaTec SPECT/computed tomography and rest perfusion SPECT imaging. Tracer uptake in the infarcted area, spleen, bone marrow, and blood pool were used for semiquantitative analysis and calculation of signal-to-background ratios. The extent and intensity of SPECT-derived inflammatory changes were compared with serological markers and perfusion defects. RESULTS: CXCR4-directed SPECT was positive in all patients. Increased CXCR4 expression was only detected in areas with diminished perfusion corresponding to the affected vessel in coronary angiography, with a signal-to-background ratio (infarcted area-to-blood pool) of 2.36±0.74. Uptake in bone marrow and spleen showed a significant correlation with CXCR4 expression in the infarcted areas (r=0.73 and P =0.03 for spleen and r=0.81 and P =0.008 for bone marrow, respectively). The extent and intensity of SPECT-derived inflammatory changes showed no significant association with serum troponin, CK (creatine kinase), leukocyte, or CRP (C-reactive protein) levels. CONCLUSIONS: This is the first report of in vivo CXCR4 imaging after AMI using a 99m Tc-labeled tracer. Increased CXCR4 expression was observed locally in the infarcted region and was related to a systemic inflammatory response in the reticuloendothelial system. This proof-of-concept investigation demonstrates the general feasibility of evaluating the inflammation-related CXCR4 expression in the myocardium after AMI using conventional scintigraphy or SPECT and might, thus, broaden its worldwide application in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionReceptors, CXCR4RadiopharmaceuticalsSingle Photon Emission Computed Tomography Computed TomographyHumansRetrospective StudiesMaleFemaleMiddle AgedAgedMyocardiumOrganotechnetium CompoundsMyocardial Perfusion ImagingPredictive Value of TestsCoronary AngiographyUp-Regulation

Stichwörter der Autor:innen

diagnostic imagingmyocardial infarctionmyocytes, cardiacstroke volumeventricular function, left

Substanzen

Receptors, CXCR4RadiopharmaceuticalsCXCR4 protein, humanOrganotechnetium Compounds

Autor:innen und Institutionen

  • Nuclear Medicine, Faculty of Medicine (A.L., R.A.B., C.H.P., M.K., G.W., C.L.), University of Augsburg, Germany.
  • Cardiology, Faculty of Medicine (P.R., M.R.), University of Augsburg, Germany.
  • Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Germany (S.G.N.).
  • Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Oncology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Switzerland (M.S.).
  • Comprehensive Heart Failure Center and Department of Nuclear Medicine, University Hospital Würzburg, Germany (T.H.).

ORCID-Profile: Alessandro Liebich, Christian H Pfob, Georgine Wienand, Stephan G Nekolla, Margret Schottelius, Takahiro Higuchi, Maximilian Rieger

Zitieren

APA

Liebich, A., Bundschuh, R. A., Pfob, C. H., Kircher, M., Wienand, G., Raake, P., Nekolla, S. G., Schottelius, M., Higuchi, T., Rieger, M., & Lapa, C. (2024). [ 99m Tc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.124.016992

Vancouver

Liebich A, Bundschuh RA, Pfob CH, Kircher M, Wienand G, Raake P, et al. [ 99m Tc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction. Circulation: Cardiovascular Imaging. 2024. doi:10.1161/circimaging.124.016992

BibTeX
@article{Liebich2024,
  author = {Liebich, Alessandro and Bundschuh, Ralph A and Pfob, Christian H and Kircher, Malte and Wienand, Georgine and Raake, Philip and Nekolla, Stephan G and Schottelius, Margret and Higuchi, Takahiro and Rieger, Maximilian and Lapa, Constantin},
  title = {[ 99m Tc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2024},
  doi = {10.1161/circimaging.124.016992}
}
Kostenlos starten →